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Abstract 
Incubation of hepatocytes under conditions known to increase their volume, i.e. with amino acids (glutamine, proline) or in hypo-osmotic medium, 
decreased carnitine palmitoyl-transferase I (CPT-I) activity. This effect of hepatocyte swelling was antagonized by okadaic acid and dibutyryl-CAMP. 
Physiological concentrations of glutamate inhibited CPT-I activity in digitonin-permeabilized hepatocytes but not in isolated mitochondria. Results 
suggest that the amino acid-induced inhibition of CPT-I shares a common mechanism with the amino acid-induced stimulation of acetyl-CoA 
carboxylase and glycogen synthase [(1993) Eur. J. Biochem. 217, 1083-10891. 
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1. Introduction 2. Experimental 
Evidence is rapidly accumulating that changes in 
hepatocyte volume play an important role in the control 
of hepatocellular metabolic function [ 1,2]. Hepatocyte 
swelling induced by several amino acids, notably glutam- 
ine and proline, or by hypotonicity have a number of 
anabolic and anti-catabolic effects, such as stimulation 
of glycogen [3,4], lipid [4] and protein synthesis [5], or 
inhibition of glycogenolysis [6] and proteolysis [7]. Keto- 
genesis is also inhibited by hepatocyte swelling [8]. Al- 
though the mechanism responsible for this effect has not 
been described, amino acid-induced inhibition of hepatic 
ketogenesis was observed to be independent of changes 
in the concentration of malonyl-CoA [8], a physiological 
inhibitor of the key regulatory enzyme in the transport 
of long-chain fatty acids into the mitochondrial matrix, 
viz. carnitine palmitoyltransferase I (CPT-I) [9%12]. 
Changes in the kinetic characteristics of CPT-I that 
occur in parallel with, or independently of, intracellular 
malonyl-CoA concentration have been shown to be in- 
volved in a number of short- and long-term alterations 
of hepatic ketogenesis [9%12]. Therefore, the present 
work was undertaken to test whether changes in the 
intrinsic properties of CPT-I are involved in the amino 
acid-induced inhibition of hepatic ketogenesis. 
*Corresponding author. Fax: (34) (1) 394 4159. 
2.1. Hepatocyte isolation and incubation 
Male Wistar rats (220-250 g) were used throughout this study. Hepa- 
tocytes were isolated as described in [13] and incubated in Krebs- 
Henseleit bicarbonate buffer supplemented with 10 mM glucose and 1% 
(w/v) defatted and dialysed bovine serum albumin. Incubations (&6 mg 
of cellular protein/ml) were carried out in a total volume of 2 ml at 37” C 
under an atmosphere of O,/CO, (19:l). The osmolarity of the medium 
(305 mOsm under iso-osmotic conditions) was varied to 225 mOsm 
(hypo-osmotic medium) or to 385 mOsm (hyper-osmotic medium) by 
changing NaCl concentration. 
2.2. Rate of ketogenesis 
The rate of ketogenesis was monitored in incubations containing 0.4 
mM [l-‘4C]palmitate (0.1 Ci/mol) bound to albumin. Reactions were 
stopped with 0.5 ml of 2 M perchloric acid and ketone bodies were 
extracted and quantified as described before [14,15]. Ketone bodies 
routinely accounted for 85-90% of total oxidation products. 
2.3. CPT-I assay 
CPT-I activity was determined as the tetradecylglycydate (TDGA)- 
sensitive incorporation of radiolabelled L-carnitine into palmitoylcar- 
nitine by three different methods (A, B and C). TDGA is a potent, 
specific and irreversible inhibitor of CPT-I [14,16]. In brief, hepatocytes 
were incubated in the absence or in the presence of 5 PM TDGA. 
Aliquots were removed from both sets of incubations in order to mon- 
itor CPT activity. In methods A and B, CPT activity was measured in 
digitonin-permeabilized hepatocytes. Both methods were performed 
using the same detergent/cell protein ratio (ca. 40 pug digitonin/mg cell 
protein). In method A (‘one-step assay’), 100 ,uI of hepatocyte suspen- 
sion was added to 100 ,~l of prewarmed digitonin-containing assay 
medium exactly as described in [15], and so the cell permeabilization 
and enzyme assay were performed at the same time. In method B 
(‘two-step assay’), hepatocytes were permeabilized and thorougly 
washed prior to determination of enzyme activity. Thus, 1.0 ml of 
hepatocyte suspension was added to 1.0 ml of prewarmed medium 
containing 0.20 mg digitonin, 5 mM Tris-HCI (pH 7.4), 150 mM KCI, 
5 mM EDTA and 5 mM EGTA (Cl- medium). The resulting mix was 
gently shaken for 5 s and rapidly diluted by transfer to tubes containing 
40 ml of ice-cold Cl- medium. Permeabilized cells were sedimented by 
centrifugation at 350 x g for 15 s, and pellets were resuspended in 1 .O 
ml of prewarmed digitonin-free Cl- medium. The permeabilized-cell 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDI 0014-5793(94)00405-K 
240 M. Guzmdn et al. IFEBS Letters 344 (1994) 239-241 
suspensions were incubated at 37°C for 5-15 min and then CPT activity 
was monitored. Finally, the third method (method C) measures enzyme 
activity in mitochondria isolated from hepatocyte suspensions as de- 
scribed in [17]. When the direct effect of glutamate on CPT-I activity 
was studied, iso-osmotic controls were always run in parallel by replac- 
ing potassium glutamate for identical concentrations of KCl. 
3. Results and discussion 
Incubation of isolated hepatocytes in conditions 
known to increase their volume, i.e. with amino acids (10 
mM glutamine or 10 mM proline) or in hypo-osmotic 
(225 mOsm) medium, decreased CPT-I activity, as meas- 
ured in digitonin-permeabilized cells by method A (Table 
1). This was accompanied by an inhibition of hepatic 
ketogenesis from palmitate in parallel cell incubations 
(Table 1). In contrast, a slight increase in CPT-I activity 
and in ketogenesis from palmitate was observed in hepa- 
tocytes incubated in hyper-osmotic (385 mOsm) medium 
(Table 1). 
The inhibition of CPT-I and ketogenesis by hepato- 
cyte swelling could result from an increase in the intracel- 
lular levels of malonyl-CoA, a physiological inhibitor of 
Table 1 
Inhibition of CPT-I activity and ketogenesis by hepatocyte swelling and 
its reversal by okadaic acid and dibutyryl-CAMP 
Cell incubation Percentage of incubations 
with no additions 
Hypo-osmotic medium (n = 6) 
Hyper-osmotic medium (n = 4) 
10 mM glutamine (n = 6) 
10 mM proline (n = 4) 
0.5 PM okadaic acid (n = 6) 
50 PM dibutyryl-CAMP (n = 6) 
Hypo-osmotic medium + 0.5 ,uM 
okadaic acid (n = 6) 
Hypo-osmotic medium + 50 ,uM 
dibutyryl-CAMP (n = 4) 
10 mM glutamine + 0.5 PM 
okadaic acid (n = 6) 
10 mM glutamine + 50 ,uM 
dibutyryl-CAMP (n ~4) 
10 mM proline + 0.5 PM okadaic 
acid (n = 4) 
10 mM proline + 50 /LM 
dibutyryl-CAMP n = 4) 
CPT-I 
activity 
Rate of 
ketogenesis 
78.5 f 5.4” 
118.1 f 3.7” 
74.7 +_ 6.0” 
68.9 f 8.3” 
154.6 + 14.7” 
137.2 + 5.1” 
149.6 t 10.2” 
136.4 + 5.7” 
142.0 f 8.5” 
133.2 f 5.0” 
145.9 + 6.9” 
126.8 f 4.0” 
81.9 + 7.0” 
116.0 f 4.5” 
78.4 f 5.3” 
74.7 f 8.1” 
148.6 f 12.1” 
132.4 f 5.7” 
140.7 f 8.4” 
133.9 + 3.2” 
143.4 f 9.3” 
128.1 f 4.4” 
139.5 & 10.4” 
126.1 f 3.7” 
Hepatocytes were incubated for 30 min in the presence of the additions 
indicated. Then, part of the cells were used for measurement of CPT-I 
activity in digitonin-permeabilized hepatocytes by method A. The rest 
of the cells were used for determination of the rate of ketogenesis from 
[1L’4C]palmitate. Results represent the means f SD. of the number of 
cell preparations indicated in every case. 100% values of CPT-I activity 
and ketogenesis were 2.16 f 0.43 nmol product/min x mg cell protein 
and 78.5 f 8.0 nmol palmitate into product/h x mg cell protein, respec- 
tively. As determined by the Student’s t-test, Significantly different 
(P < 0.01) from incubations with no additions. 
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Fig. 1. Inhibition of CPT-I activity by glutamate in digitonin-permea- 
bilized hepatocytes and its reversal by hepatocyte pretreatment with 
okadaic acid. Hepatocytes were incubated for 30 min with no additions 
(Y) or in the presence of either 10 mM glutamine (0). 0.5 PM okadaic 
acid (o), or 10 mM glutamine plus 0.5,~M okadaic acid (m). Then, cells 
were permeabilized, washed in an excess of Cl- medium, and incubated 
at 37°C for 5-15 min with increasing concentrations of glutamate. 
CPT-I activity was determined in those permeabilized cells by method 
B. Alternatively, CPT-I activity was determined by method C in mito- 
chondria isolated from hepatocytes incubated with no additions (.:). 
Results represent the means + SD. of 4 cell preparations. 
CPT-I [9-121. However, Baquet et al. have shown that 
the amino acid-induced inhibition of hepatic ketogenesis 
can occur independently of increases in malonyl-CoA 
concentration [8]. In the present study, the simultaneous 
permeabilization of the plasma membrane and assay of 
CPT-I activity (method A) is assumed to have diluted 
intracellular malonyl-CoA [14,15]. Consequently, it is 
possible that the observed changes in CPT-I activity are 
due to stable post-translational modification of CPT-I, 
either directly [ 14,1.5,18] or indirectly [ 191. Therefore, we 
tested whether factors that increase cell protein phospho- 
rylation (e.g. dibutyryl-CAMP, okadaic acid) could pre- 
vent the observed effects of swelling. Table 1 shows that 
both agents were able to antagonize the effects of swel- 
ling on CPT-I activity. 
In another set of experiments, hepatocytes were incu- 
bated with glutamine and/or okadaic acid, and CPT-I 
activity was determined in digitonin-permeabilized hepa- 
tocytes by method B (Fig. 1). The changes induced by 
these cellular effecters on CPT-I activity survived perme- 
abilization of hepatocytes, extensive washing of the per- 
meabilized cells, and subsequent incubation of the per- 
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meabilized cells at 37°C for 5-15 min, again indicating 
that the modulation of enzyme activity is stable. There- 
fore, although the inhibition of CPT-I by malonyl-CoA 
is a well-described property of the enzyme [9-121, other 
types of regulatory mechanisms could be involved in the 
control of hepatic CPT-I by hepatocyte swelling. Since 
the changes observed in CPT-I activity are stable in spite 
of the absence of fluoride in the medium, they are un- 
likely to be due to changes in the phosphorylation state 
of CPT-I. 
A mechanism linking amino acid-induced hepatocyte 
swelling to stimulation of glycogen synthesis and lipo- 
genesis has been recently suggested. Thus, the increase 
in the intracellular concentration of glutamate and (to a 
lesser extent) aspartate that is observed in swollen hepa- 
tocytes after incubation with glutamine or proline seem 
to be responsible, at least in part, for the stimulation of 
protein phosphatase(s) involved in the activation of gly- 
cogen synthase (and hence of glycogen synthesis) [20] 
and acetyl-CoA carboxylase (and hence of lipogenesis) 
[21]. Therefore, we wondered whether a similar mecha- 
nism could be responsible for the inhibition of CPT-I 
(and hence of ketogenesis independently of malonyl- 
CoA concentration) by hepatocyte swelling. From data 
presented in Fig. 1 it may be inferred that (i) concentra- 
tions of glutamate found in hepatocytes incubated with 
glutamine or proline [20] inhibited CPT-I when enzyme 
activity was assayed by method B in digitonin-permea- 
bilized hepatocytes; (ii) preincubation of hepatocytes 
with glutamine induced a certain desensitization of the 
CPT-I enzyme toward glutamate; (iii) preincubation of 
hepatocytes with okadaic acid rendered CPT-I insensi- 
tive to the inhibitory effect of glutamate. Therefore, re- 
sults suggest that the amino acid-induced inhibition of 
hepatic CPT-I may result from a glutamate-dependent 
mechanism related to that involved in the activation of 
glycogen synthase [20] and acetyl-CoA carboxylase [21]. 
It has recently been shown that the okadaic acid-in- 
duced stimulation of CPT-I is retained when mitochon- 
dria are still associated with other cellular fractions, e.g. 
in permeabilized cell ghosts and in crude cellular homo- 
genates, but not when mitochondria are isolated for de- 
termination of enzyme activity [19]. Likewise, the inhibi- 
tion of CPT-I by glutamate observed in permeabilized 
hepatocytes (Table 1 and Fig. 1) was not evident when 
enzyme activity was assayed by method C in mitochon- 
dria isolated from hepatocyte suspensions (Fig. 1). Oka- 
daic acid is known to disrupt the cytoskeleton [22], and 
some effects of hepatocyte swelling are abolished by 
hepatocyte preincubation with colchicine, i.e. they seem 
to depend on the integrity of the cytoskeleton [23]. How- 
ever, when we preincubated hepatocytes with colchicine 
or cytochalasin B, the effects of glutamine and okadaic 
acid on CPT-I activity were still evident (results not 
shown), suggesting that the integrity of the cytoskeleton 
is not necessary for the modulation of CPT-I activity by 
these cellular effecters. Our current research focuses on 
the characterization of the extra-mitochondrial cell com- 
ponents, presumably non-diffusible and possibly mem- 
branous, which seem to be required for the effects of 
glutamine or okadaic acid on CPT-I activity to be ob- 
served. 
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